In this series from the CFAR National Symposium on HIV/AIDS Prevention & Transmission 2007, you will hear from experts from universities throughout the US and...
Do HAART therapies increase your risk for cardiovascular disease? As you partner with your doctor, these are important questions to consider as part of choosing...
NEW YORK (Reuters Health) -- For many patients with HIV receiving highly active antiretroviral therapy (HAART), routine bone mineral density (BMD) assessment may not be...